CYCLOSPORINE PHARMACOKINETICS IN PANCREAS TRANSPLANT RECIPIENTS

被引：0
|
作者：
MUNDA, R
SCHROEDER, TJ
PEDERSEN, SA
CLARDY, CW
WADHWA, NK
MYRE, SA
STEPHENS, GW
PESCE, AJ
ALEXANDER, JW
FIRST, MR
机构：
[1] UNIV CINCINNATI,MED CTR,DEPT PATHOL & LAB MED,CINCINNATI,OH 45267
[2] UNIV CINCINNATI,MED CTR,DEPT INTERNAL MED,CINCINNATI,OH 45267
[3] UNIV CINCINNATI,MED CTR,DEPT PHARM,CINCINNATI,OH 45267
[4] CHILDRENS HOSP MED CTR,CINCINNATI,OH 45229
来源：
TRANSPLANTATION PROCEEDINGS | 1988年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：487 / 490
页数：4
相关论文
共 50 条
  • [21] PHARMACOKINETICS AND THERAPEUTIC MONITORING OF CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS
    CHEYMOL, G
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1992, 176 (07): : 1023 - 1032
  • [22] Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors
    Akhlaghi, F
    Keogh, AM
    McLachlan, AJ
    Kaan, A
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (04): : 431 - 438
  • [23] Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients
    ElGhoroury, M
    Hariharan, S
    Peddi, VR
    Munda, R
    Schroeder, TJ
    Demmy, AM
    Alexander, JW
    First, MR
    [J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 649 - 651
  • [24] EFFECT OF CYCLOSPORINE ON THE ENDOCRINE AND EXOCRINE PANCREAS IN KIDNEY-TRANSPLANT RECIPIENTS
    YOSHIMURA, N
    NAKAI, I
    OHMORI, Y
    AIKAWA, I
    FUKUDA, M
    YASUMURA, T
    MATSUI, S
    HAMASHIMA, T
    OKA, T
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 12 (01) : 11 - 17
  • [25] ORAL CYCLOSPORINE PHARMACOKINETICS IN PEDIATRIC RENAL AND LIVER-TRANSPLANT RECIPIENTS
    COONEY, GF
    DUNN, SP
    KAISER, B
    KULINSKY, AV
    MOCHON, M
    HEIFETS, M
    [J]. TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2779 - 2780
  • [26] Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and myfortic
    Brunet, M.
    Crespo, M.
    Millan, O.
    Seron, D.
    Torregrosa, V.
    Jimenez, O.
    Moreso, F.
    Martorell, J.
    Grinyo, J. M.
    Oppenheimer, F.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2160 - 2162
  • [27] PHARMACOKINETICS OF A NEW ORAL FORMULATION OF CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS
    FREEMAN, D
    GRANT, D
    LEVY, G
    ROCHON, J
    WONG, PY
    ALTRAIF, I
    ASFAR, S
    [J]. THERAPEUTIC DRUG MONITORING, 1995, 17 (03) : 213 - 216
  • [28] Cyclosporine pharmacokinetics and risk of recurrent rejection in recipients of simultaneous pancreas/kidney transplants
    Kaplan, B
    Wang, Z
    Abecassis, M
    Stuart, FP
    Kaufman, DB
    [J]. THERAPEUTIC DRUG MONITORING, 1996, 18 (05) : 556 - 561
  • [29] CYCLOSPORINE-ASSOCIATED LESIONS IN NATIVE KIDNEYS OF DIABETIC PANCREAS TRANSPLANT RECIPIENTS
    FIORETTO, P
    STEFFES, MW
    MIHATSCH, MJ
    STROM, EH
    SUTHERLAND, DER
    MAUER, M
    [J]. KIDNEY INTERNATIONAL, 1995, 48 (02) : 489 - 495
  • [30] Comparison of Tacrolimus and Cyclosporine Nephrotoxicity in Native Kidneys of Diabetic Pancreas Transplant Recipients
    Najafian, B.
    Fioretto, P.
    Sutherland, D.
    Mauer, M.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 343A - 343A
12345